On January 9, 2023, the U.S. House of Representatives adopted its rules package for the 118th Congress (“House Rules”) by a vote of 220 to 213. While much attention has been given to the provisions that would significantly...more
Six months into the 117th Congress, the U.S. Senate has recently increased its oversight activities following a slow start. Since April, newly empowered Democratic Members have launched or requested more than 20 inquiries...more
7/6/2021
/ Anti-Competitive ,
Biden Administration ,
Congressional Oversight ,
Coronavirus/COVID-19 ,
Cryptocurrency ,
Cybersecurity ,
Diversity and Inclusion Standards (D&I) ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Manufacturers ,
Pharmaceutical Industry ,
Popular ,
Relief Measures